<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02126774</url>
  </required_header>
  <id_info>
    <org_study_id>12-02865</org_study_id>
    <nct_id>NCT02126774</nct_id>
  </id_info>
  <brief_title>The Human Epilepsy Project</brief_title>
  <acronym>HEP</acronym>
  <official_title>The Human Epilepsy Project</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Epilepsy Study Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HEP is a five-year, prospective, observational study whose primary goal is to identify&#xD;
      clinical characteristics and biomarkers predictive of disease outcome, progression, and&#xD;
      treatment response in participants with newly treated focal epilepsy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Epilepsy is a serious disease. It affects approximately 2.4 million Americans, with a&#xD;
      lifetime risk estimated at 3%. More than 181,000 Americans develop epilepsy every year, and a&#xD;
      substantial proportion has seizures that cannot be controlled by available medications. For&#xD;
      the vast majority of patients with epilepsy, we do not understand the biological basis of&#xD;
      their disease; we do not know whether a given anti-epileptic drug (AED) will be effective;&#xD;
      and we cannot predict the severity of the seizure disorder, the potential emergence of&#xD;
      co-morbidities, or the likelihood of remission.&#xD;
&#xD;
      The Human Epilepsy Project seeks to answer these unknowns by collecting high-resolution&#xD;
      clinical information and treatment response, MRIs, EEGs, and blood and urine samples for&#xD;
      biomarkers. A major outcome of the project is to create an open data repository of clinical&#xD;
      information and biologic samples for future studies.&#xD;
&#xD;
      HEP may have a transformative impact on epilepsy diagnosis and treatment by identifying&#xD;
      critical clinical features and biomarkers at the onset of epilepsy that can be used to&#xD;
      predict outcome and guide therapy. We hope to identify subsets of patients at high risk for&#xD;
      pharmacoresistance who may benefit from more aggressive initial therapy and earlier&#xD;
      consideration for surgical treatment. The existence of biomarkers that predict the likelihood&#xD;
      of disease remission would dramatically affect treatment decisions and counseling for&#xD;
      millions of patients.&#xD;
&#xD;
      In addition to its impact on current clinical care, the data and specimens collected in HEP,&#xD;
      including sequential neuroimaging, electrophysiology and metabolite profiles, and banked DNA&#xD;
      for the purpose of future genomics studies, have the potential to provide new insights into&#xD;
      the biological basis of focal epilepsy, which will advance our efforts to discover effective&#xD;
      treatments and cures for this disorder.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2012</start_date>
  <completion_date type="Actual">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Presence of Biomarker(s) Predictive of Anti-epileptic Drug Treatment Response</measure>
    <time_frame>up to 36 months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">488</enrollment>
  <condition>Focal Epilepsy</condition>
  <arm_group>
    <arm_group_label>focal epilepsy</arm_group_label>
    <description>observational study</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      whole blood, plasma, urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Epilepsy/Neurology clinical centers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Clinical seizure(s) and history consistent with focal epilepsy&#xD;
&#xD;
          -  At least two confirmed spontaneous seizures, at least 24 hours apart, in the 12 months&#xD;
             prior to enrollment&#xD;
&#xD;
          -  Complete AED history prior to enrollment (with approximate dates and doses) is&#xD;
             available (exception can be made for AEDs taken for &lt;1 week)&#xD;
&#xD;
          -  Age ≥12 years and ≤60 years at time of seizure onset&#xD;
&#xD;
          -  Age ≥12 years and ≤60 years at time of enrollment&#xD;
&#xD;
          -  Treatment instituted not more than 4 months prior to enrollment&#xD;
&#xD;
          -  One of the following:&#xD;
&#xD;
               1. Normal MRI with inter-ictal EEG showing focal abnormality (focal sharp waves or&#xD;
                  focal slowing)&#xD;
&#xD;
               2. Normal MRI and normal inter-ictal EEG, with clinical or electrographic seizure&#xD;
                  activity on ictal EEG&#xD;
&#xD;
               3. Definitive clinical history of recurrent seizures consistent with focal epilepsy,&#xD;
                  adjudicated by central reviewers, if normal MRI and normal EEG&#xD;
&#xD;
               4. Focal lesion (non-progressive) on MRI with normal EEG (acceptable focal lesions&#xD;
                  include MTS, FCD, single cavernoma, and AVMs that are not of large size and lack&#xD;
                  significant amounts of hemosiderin)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Idiopathic or symptomatic generalized epilepsy&#xD;
&#xD;
          -  Any epilepsy etiology that could produce significant gliosis or brain injury and would&#xD;
             be likely to alter biomarkers. These include:&#xD;
&#xD;
               1. Epilepsy with an etiology occurring in the previous two years that would produce&#xD;
                  significant CNS injury (e.g., traumatic brain injury that involves direct&#xD;
                  disruption of brain tissue, stroke, encephalitis)&#xD;
&#xD;
               2. History of intracranial bleeding (e.g., subarachnoid, intraparenchymal)&#xD;
&#xD;
          -  Identified genetic epilepsy syndrome&#xD;
&#xD;
          -  Presence of moderate or greater developmental or cognitive delay prior to seizure&#xD;
             onset (e.g., if an adolescent, not in self-contained classroom; if IQ is documented,&#xD;
             should be &gt; 70)&#xD;
&#xD;
          -  History of chronic drug or alcohol abuse within the last 2 years&#xD;
&#xD;
          -  IGE/focal epilepsy mixed syndromes&#xD;
&#xD;
          -  Progressive neurological disorder (brain tumor, AD, PME, etc.)&#xD;
&#xD;
          -  Major medical co-morbidities such as renal failure requiring dialysis, metastatic&#xD;
             cancer, HIV, or significant liver or renal disease&#xD;
&#xD;
          -  Autism Spectrum Disorder&#xD;
&#xD;
          -  Seizures only during pregnancy&#xD;
&#xD;
          -  History of previous or current significant psychiatric disorder that would interfere&#xD;
             with conduct of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruben Kuzniecky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University, Comprehensive Epilepsy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacqueline French, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University, Comprehensive Epilepsy Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Daniel Lowenstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco, Department of Neurology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mid-Atlantic Epilepsy and Sleep Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Minnesota Epilepsy Group</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Barnabas Medical Center</name>
      <address>
        <city>Livingston</city>
        <state>New Jersey</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore-LIJ Health System</name>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albert Einstein College of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York University Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Geisinger Medical Center</name>
      <address>
        <city>Danville</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Hospital, University of Melbourne</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Melbourne</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prince of Wales Hospital, University of New South Wales</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Western Ontario</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://humanepilepsyproject.org</url>
    <description>HEP website</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 28, 2014</study_first_submitted>
  <study_first_submitted_qc>April 28, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2014</study_first_posted>
  <last_update_submitted>July 2, 2021</last_update_submitted>
  <last_update_submitted_qc>July 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>epilepsy</keyword>
  <keyword>focal epilepsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Epilepsies, Partial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

